Free Trial

Novo Nordisk A/S (NVO) Short Interest Ratio & Short Volume

Novo Nordisk A/S logo
$37.31 -0.09 (-0.24%)
Closing price 10/2/2026 03:59 PM Eastern
Extended Trading
$37.29 -0.02 (-0.05%)
As of 10/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Novo Nordisk A/S Short Interest Overview

As of September 15, 2026, Novo Nordisk A/S (NVO) had a short interest of 26.34 million shares sold short, representing 0.59% of the public float. This marks a -16.78% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.9, meaning it would take 2.9 days of the average trading volume of 13.54 million shares to cover all short positions.

Current Short Interest
26,339,706 shares
Previous Short Interest
31,648,914 shares
Change Vs. Previous Month
-16.78%
Dollar Volume Sold Short
$1.12 billion
Short Interest Ratio
2.9 Days to Cover
Last Record Date
September 15, 2026
Outstanding Shares
4,465,000,000 shares
Short Percent of Float
0.59%
Today's Trading Volume
10,168,387 shares
Average Trading Volume
13,542,187 shares
Today's Volume Vs. Average
75%
Short Selling Novo Nordisk A/S?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Novo Nordisk A/S and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

NVO Short Interest Over Time

NVO Days to Cover Over Time

NVO Percentage of Float Shorted Over Time

Novo Nordisk A/S Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/202626,339,706 shares $1.12 billion -16.8%0.6%2.92 $42.43
8/31/202631,648,914 shares $1.43 billion -6.4%0.7%2.68 $45.34
8/14/202633,828,864 shares $1.55 billion +15.0%0.8%2.18 $45.91
7/31/202629,424,036 shares $1.39 billion -5.4%0.7%2.89 $47.20
7/15/202631,094,150 shares $1.57 billion +11.9%0.7%3.34 $50.56
6/30/202627,780,646 shares $1.33 billion +13.5%0.6%2.2 $47.92
6/15/202624,478,152 shares $1.07 billion +7.9%0.5%1.7 $43.85
5/29/202622,683,612 shares $1.03 billion +4.4%0.5%1.95 $45.57
5/15/202621,723,616 shares $971.26 million +55.2%0.5%1.21 $44.71
4/30/202613,996,269 shares $591.15 million -17.8%0.3%0.78 $42.24
4/15/202617,019,927 shares $694.45 million -14.6%0.4%1.11 $40.80
3/31/202619,927,815 shares $731.49 million -19.3%0.4%1.1 $36.71
3/13/202624,696,357 shares $938.12 million -12.6%0.6%1.19 $37.99
2/27/202628,261,287 shares $1.06 billion +4.8%0.6%0.85 $37.50
2/13/202626,973,270 shares $1.34 billion -14.9%0.6%0.88 $49.59
1/30/202631,693,294 shares $1.88 billion +12.6%0.7%1.38 $59.40
1/15/202628,156,368 shares $1.61 billion -13.1%0.6%1.29 $57.07
12/31/202532,384,787 shares $1.65 billion +13.7%0.7%1.79 $50.88
12/15/202528,487,274 shares $1.44 billion -3.7%0.6%2.09 $50.38
11/28/202529,593,438 shares $1.46 billion +6.9%0.7%1.22 $49.35
11/14/202527,691,852 shares $1.34 billion -2.0%0.6%1.16 $48.22
10/31/202528,242,397 shares $1.40 billion +5.9%0.6%2.35 $49.40
10/15/202526,670,000 shares $1.51 billion -15.2%0.6%1.5 $56.72
9/30/202531,460,000 shares $1.75 billion +9.5%N/A1.8 $55.52
9/15/202528,740,000 shares $1.60 billion +11.5%N/A1.7 $55.62
8/31/202525,780,000 shares $1.46 billion +22.7%0.6%1.6 $56.51
8/15/202521,020,000 shares $1.10 billion +1.3%N/A1.4 $52.43
7/31/202520,760,000 shares $976.11 million -12.0%0.5%1.5 $47.02
7/15/202523,580,000 shares $1.59 billion -8.3%N/A2.5 $67.32
6/30/202525,700,000 shares $1.77 billion -3.4%0.6%2.5 $69.06
6/15/202526,610,000 shares $2.13 billion -21.0%0.6%2.6 $79.90
5/31/202533,670,000 shares $2.40 billion +22.1%0.8%3.4 $71.40
5/15/202527,580,000 shares $1.82 billion +9.8%0.6%2.9 $66.07
4/30/202525,120,000 shares $1.67 billion +31.7%N/A2.7 $66.53
4/15/202519,070,000 shares $1.23 billion +30.1%0.4%2.1 $64.46
3/31/202514,660,000 shares $1.02 billion +16.0%0.3%1.7 $69.58
3/15/202512,640,000 shares $976.09 million -6.4%0.3%1.4 $77.22
2/28/202513,510,000 shares $1.23 billion -0.2%0.3%1.5 $90.68
2/15/202513,530,000 shares $1.05 billion -0.3%0.3%1.6 $77.94
1/31/202513,570,000 shares $1.14 billion +64.1%N/A1.7 $84.36
WATCH THIS BEFORE DECEMBER 8th!! (Ad)

James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it. Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge.tc pixel

Watch the free breakdown before December 8th to learn more
1/15/20258,270,000 shares $686.33 million -0.4%N/A1.1 $82.99
12/31/20248,300,000 shares $713.97 million +76.6%N/A1.3 $86.02
12/15/20244,700,000 shares $502.67 million -17.3%N/A0.8 $106.95
11/30/20245,680,000 shares $606.62 million +15.2%N/A1.1 $106.80
11/15/20244,930,000 shares $501.58 million -18.5%N/A1 $101.74
10/31/20246,050,000 shares $677.36 million -4.9%N/A1.4 $111.96
10/15/20246,360,000 shares $749.40 million -9.5%N/A1.6 $117.83
9/30/20247,030,000 shares $836.92 million +21.2%N/A1.7 $119.05
9/15/20245,800,000 shares $794.60 million +13.1%N/A1.5 $137.00
8/31/20245,130,000 shares $713.89 million -2.7%N/A1.3 $139.16
8/15/20245,270,000 shares $724.99 million +30.1%N/A1.3 $137.57
7/31/20244,050,000 shares $537.15 million +28.6%N/A1 $132.63
7/15/20243,150,000 shares $445.38 million -30.3%N/A0.8 $141.39
6/30/20244,520,000 shares $645.18 million +3.7%N/A1.2 $142.74
6/15/20244,360,000 shares $621.30 million -2.7%N/A1.2 $142.50
5/31/20244,480,000 shares $606.14 million +20.8%N/A1.1 $135.30
5/15/20243,710,000 shares $499.51 million +1.9%N/A0.8 $134.64
4/30/20243,640,000 shares $466.94 million +12.4%N/A0.8 $128.28
4/15/20243,240,000 shares $401.27 million +14.5%N/A0.6 $123.85
3/31/20242,830,000 shares $363.37 million -31.1%N/A0.6 $128.40
3/15/20244,110,000 shares $543.96 million -15.8%N/A0.8 $132.35
2/29/20244,880,000 shares $584.33 million +4.5%N/A1 $119.74
2/15/20244,670,000 shares $568.43 million -37.9%N/A1 $121.72
1/31/20247,520,000 shares $862.47 million +37.7%N/A1.7 $114.69
1/15/20245,460,000 shares $585.09 million -5.0%N/A1.3 $107.16
12/31/20235,750,000 shares $594.84 million -11.1%N/A1.3 $103.45
12/15/20236,470,000 shares $628.04 million +15.5%N/A1.4 $97.07
11/30/20235,600,000 shares $570.33 million -6.2%N/A1.2 $101.85
11/15/20235,970,000 shares $575.63 million +34.8%N/A1.3 $96.42
10/31/20234,430,000 shares $427.81 million -26.3%N/A1 $96.57
10/15/20236,010,000 shares $613.86 million +1.7%N/A1.3 $102.14
9/30/20235,910,000 shares $537.46 million +5.4%N/A1.5 $90.94
9/15/20235,610,000 shares $267.03 million +187.7%0.3%1.6 $47.60
8/31/20231,950,000 shares $362.15 million -4.9%0.1%1.2 $185.72
8/15/20232,050,000 shares $379.50 million +106.0%0.1%1.4 $185.12
7/31/2023995,300 shares $160.34 million -21.0%0.1%0.7 $161.10
7/15/20231,260,000 shares $201.78 million -44.3%0.1%1 $160.14
6/30/20232,260,000 shares $365.74 million +9.2%0.1%1.6 $161.83
6/15/20232,070,000 shares $336.44 million +16.3%0.1%1.5 $162.53
5/31/20231,780,000 shares $285.69 million +14.1%0.1%1.3 $160.50
5/15/20231,560,000 shares $264.31 million +6.1%0.1%1.1 $169.43
4/30/20231,470,000 shares $245.62 million -14.5%0.1%1.1 $167.09
4/15/20231,720,000 shares $289.99 million -26.2%0.1%1.2 $168.60
3/31/20232,330,000 shares $370.80 million +66.4%0.1%1.7 $159.14
3/15/20231,400,000 shares $197.37 million +28.4%0.1%1 $140.98
2/28/20231,090,000 shares $153.68 million -3.5%0.1%0.8 $140.99
2/15/20231,130,000 shares $159.28 million -33.9%0.1%0.8 $140.96
1/31/20231,710,000 shares $237.31 million +3.6%0.1%1.2 $138.78
1/15/20231,650,000 shares $224.93 million -10.3%0.1%1.2 $136.32
12/30/20221,840,000 shares $249.03 million +34.3%0.1%1.4 $135.34
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
12/15/20221,370,000 shares $183.14 million -34.1%0.1%1 $133.68
11/30/20222,080,000 shares $259.17 million -20.6%0.1%1.6 $124.60
11/15/20222,620,000 shares $297.74 million -1.1%0.2%1.8 $113.64
10/31/20222,650,000 shares $288.43 million -17.7%0.2%1.7 $108.84
10/15/20223,220,000 shares $334.24 million +0.9%0.2%2 $103.80
9/30/20223,190,000 shares $317.82 million +2.2%0.2%1.9 $99.63
9/15/20223,120,000 shares $322.02 million -9.0%0.2%1.9 $103.21
8/31/20223,430,000 shares $363.92 million +48.5%0.2%2.1 $106.10
8/15/20222,310,000 shares $245.71 million +76.3%0.1%1.5 $106.37
7/31/20221,310,000 shares $152.04 million +26.0%0.1%0.9 $116.06
7/15/20221,040,000 shares $118.80 million -46.4%N/A0.7 $114.23
6/30/20221,940,000 shares $216.17 million -22.7%N/A1.3 $111.43
6/15/20222,510,000 shares $266.89 million +46.8%N/A1.7 $106.33
5/31/20221,710,000 shares $188.78 million -29.1%0.1%1.2 $110.40
5/15/20222,410,000 shares $255.56 million +39.3%0.1%1.6 $106.04
4/30/20221,730,000 shares $197.22 million -47.1%0.1%1.2 $114.00
4/15/20223,270,000 shares $386.51 million +58.0%0.2%2.3 $118.20
3/31/20222,070,000 shares $229.87 million -21.3%0.1%1.4 $111.05
3/15/20222,630,000 shares $269.44 million +10.0%0.2%1.7 $102.45
2/28/20222,390,000 shares $246.05 million -4.8%0.1%1.5 $102.95
2/15/20222,510,000 shares $254.41 million -24.6%0.1%1.7 $101.36
1/31/20223,330,000 shares $332.57 million +0.3%0.2%2.4 $99.87
1/15/20223,320,000 shares $319.78 million +18.2%0.2%2.6 $96.32
12/31/20212,810,000 shares $314.72 million +42.6%0.2%2.5 $112.00
12/15/20211,970,000 shares $229.43 million +3.1%0.1%1.9 $116.46
11/30/20211,910,000 shares $204.05 million -26.0%0.1%2.2 $106.83
11/15/20212,580,000 shares $292.80 million +22.3%0.2%2.8 $113.49
10/29/20212,110,000 shares $232.37 million -17.3%0.1%2.2 $110.13
10/15/20212,550,000 shares $260.97 million +8.1%0.2%2.5 $102.34

NVO Short Interest - Frequently Asked Questions

Short interest is the volume of Novo Nordisk A/S shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 26,339,706 shares of NVO short. 0.59% of Novo Nordisk A/S's shares are currently sold short. Learn More on Novo Nordisk A/S's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NVO shares currently have a short interest ratio of 2.9. Learn More on Novo Nordisk A/S's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.59% of Novo Nordisk A/S's floating shares are currently sold short.

Novo Nordisk A/S saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 26,339,706 shares, a decline of 16.8% from the previous total of 31,648,914 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.59% of Novo Nordisk A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Novo Nordisk A/S: Johnson & Johnson (0.88%), Merck & Co., Inc. (1.40%), Novartis AG (0.27%), Astrazeneca Plc (0.13%), Pfizer Inc. (2.74%), Bristol Myers Squibb Company (2.06%), Sanofi (0.39%), GSK PLC Sponsored ADR (0.80%), Takeda Pharmaceutical Co. (0.13%), Teva Pharmaceutical Industries Ltd. (2.72%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($75.21 billion), Invesco QQQ ($46.31 billion), iShares Russell 2000 ETF ($27.98 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($9.70 billion), Canadian Natural Resources Limited ($9.42 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($8.53 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.79 billion), and Financial Select Sector SPDR Fund ($7.74 billion). View all of the most shorted stocks.

Short selling NVO is an investing strategy that aims to generate trading profit from Novo Nordisk A/S as its price is falling. NVO shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Novo Nordisk A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NVO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NVO, twice per month. The most recent reporting period available is September, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like NVO:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NYSE:NVO is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/24/2026. FINRA publishes updated short interest twice a month.
From Our Partners